Search Results 291-300 of 24106 for prostate cancer
The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene ...
While it's not the same as prostate cancer, an enlarged prostate can cause significant quality of life issues. Dr. Scott Cheney, a Mayo Clinic urologist ...
In men, radical cystectomy typically includes removal of the prostate and seminal vesicles. In women, radical cystectomy may involve removal of the uterus ...
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...
prostate cancer are expected to be diagnosed this year. "The reality is that prostate cancer is the most commonly diagnosed solid malignancy in men," says ...
... prostate cancer. The FDA recently expanded the indication of lutetium Lu 177 vipivotide tetraxetan for PSMA-positive metastatic castration-resistant prostate ...
Mayo Clinic is leading the way with a new treatment for advanced prostate cancer, specifically for prostate-specific membrane antigen-positive metastatic ...
But even early-stage bladder cancers can come back after successful treatment. For this reason, people with bladder cancer typically need follow-up tests for ...
... prostate cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
... prostate cancer who may receive a negative MRI and 2) avoiding MRI and biopsy in men with benign disease and indolent prostate cancer. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.